Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07013591
PHASE2

Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery

Sponsor: Brigham and Women's Hospital

View on ClinicalTrials.gov

Summary

The investigators will perform a phase 2a, randomized, double-blind, placebo-controlled clinical trial in adult patients undergoing elective coronary artery bypass grafting (CABG) surgery to investigate the effects of oral nicotinamide mononucleotide (NMN) administration on myocardial NAD+ concentrations and on postoperative markers of myocardial and kidney injury.

Official title: Randomized Clinical Trial of β Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-03-31

Completion Date

2029-01-01

Last Updated

2026-02-18

Healthy Volunteers

No

Interventions

DRUG

MIB-626

An orally-administered stable crystalline tablet formulation of NMN

OTHER

Placebo

matching placebo tablets

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States